Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Atavistik Bio, Inc
K36 Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
Advanced Accelerator Applications
Endocyte
Poseida Therapeutics, Inc.
Aragon Pharmaceuticals, Inc.
Celldex Therapeutics
Celldex Therapeutics
Merck Sharp & Dohme LLC
Tesaro, Inc.
Pharmacyclics LLC.